Interview, Fireside Chat
Bain Capital’s David Gross on global opportunities and private equity’s evolution
- U.S. sectors including manufacturing are expected to benefit from substantial savings, spending capacity, and government stimulus, with the U.S. positioned strongly in energy and technology.
- Japan is forecast to evolve into a significant buyout and multi-asset class market driven by converging forces, despite an increasing number of competitors entering the space.
- European markets are anticipated to present value opportunities, particularly through divestitures of export-facing businesses from German corporates and a contrarian view on tougher economies.
- India's market outlook is improving as macro issues resolve through a stable government, deeper markets, and a strategic shift toward controlling companies rather than minority stakes.
- Specific investment strategies target businesses with attractive capital structures where flat or declining operations can achieve 3–4% growth through margin improvements.
- Portfolio growth will be supported by tying macro insights on immigration and migration patterns to themes in housing development and supply-demand gaps.
- Healthcare investment strategies aim to offset funding and payer pressures by integrating healthcare with technology and thinking across business units.
- The industry is currently in the early stages of a recovery cycle where the buyer-seller gap remains wide, though some low percentage distributions relative to asset value are expected.
- Businesses are expected to grow out of current conditions supported by patient capital structures and heavy technology investments by tech companies.
- Market realizations will be driven by a focus on multiple contraction and value-oriented businesses, with the firm scaling its value creation platform to 130 dedicated personnel.
- Specialist capabilities in go-to-market strategy, procurement, IT, and technology are being developed to complement the firm's multi-asset class approach and venture capital arm.
- Artificial intelligence, data science, robotics, and machine learning are projected to provide a competitive advantage by identifying use cases and field-testing applications.
- The firm plans to maintain its core entrepreneurial culture while growing globally by operating vertically and locally, retaining mentorship and sponsorship structures.
- Rapid technological change in biotech, life sciences, and concepts like "flying cars" is viewed as a major source of opportunity and excitement despite potential apprehension.
- Embedding macro analysis into all deals will allow the firm to model scenarios regarding specific events and stay ahead of the curve.